| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/10/2013 | CA2557758C Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 09/10/2013 | CA2492498C Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 09/10/2013 | CA2456247C Use of il-18 inhibitors in hypersensitivity disorders |
| 09/10/2013 | CA2451566C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 09/06/2013 | WO2013128423A1 Use of a glycosylated-modified tetrafunctional non-ionic amphiphilic block copolymer as immune adjuvant |
| 09/05/2013 | US20130231367 Beta2-adrenoreceptor agonists |
| 09/04/2013 | EP2634188A1 Fused aminodihydropyrimidine derivative |
| 09/04/2013 | EP2634186A1 Naphthyridine derivative |
| 09/04/2013 | EP2634176A1 Pyridine derivative and medicinal agent |
| 09/04/2013 | EP2632444A1 TREATMENT OF MeCP2-ASSOCIATED DISORDERS |
| 09/04/2013 | CN103282495A Novel anti-dr5 antibody |
| 09/04/2013 | CN103282054A A pharmaceutical composition of a complex of an anti-ig antibody and digoxigenin that is conjugated to a peptide |
| 09/04/2013 | CN103282034A Use of hematopoietic growth factor mimetics |
| 09/04/2013 | CN103275159A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 09/04/2013 | CN103275033A Modulators of pharmacokinetic properties of therapeutics |
| 09/04/2013 | CN103272246A Angelica essential oil and mixed cyclodextrin clathrate and preparation method thereof |
| 09/04/2013 | CN103272235A Pharmaceutical composition for preventing or treating cold injury and thrombus |
| 09/04/2013 | CN103272225A Crystallized oxalate decarboxylase and methods of use |
| 09/04/2013 | CN103272203A Foot bathing powder for dispelling cold and tranquillizing mind |
| 09/04/2013 | CN103272161A Traditional Chinese medicine composition for treating cold limbs |
| 09/04/2013 | CN103272142A Oral liquid for nursing sunstroke patient |
| 09/04/2013 | CN103272139A Yin deficiency type night sweat treatment traditional Chinese medicine pills |
| 09/04/2013 | CN103272089A Traditional Chinese medicine oral liquid for treating poultry sunstroke and preparation method thereof |
| 09/04/2013 | CN103272069A Medicinal granules for treating thyroiditis |
| 09/04/2013 | CN103272061A Chinese medicine composition capable of avoiding plague and disinfecting |
| 09/04/2013 | CN103271995A Chinese medicinal oral liquid for preventing and treating sunstroke of laying hens and preparation method thereof |
| 09/04/2013 | CN103271994A Chinese medicinal granule for treating swine heatstroke and preparation method thereof |
| 09/04/2013 | CN103271987A Preparation method of pogostemon cablin liquid capsule |
| 09/04/2013 | CN103271957A Fennel oil-mixed cyclodextrin clathrate compound and preparation method thereof |
| 09/04/2013 | CN102973697B Traditional Chinese medicine composition particles for clearing heat and expelling damp, and preparation method thereof |
| 09/04/2013 | CN102698043B Medicinal combination for treating thyroid gland |
| 09/04/2013 | CN102526496B Traditional Chinese medicine composition for treating fire excess from yin deficiency type sleepless night sweating symptoms, and preparation method of traditional Chinese medicine composition |
| 09/04/2013 | CN101837003B Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/04/2013 | CN101460188B Treatment of ischemic disease using erythropoietin |
| 09/04/2013 | CN101269214B EG-VEGF nucleotide and using method |
| 09/03/2013 | US8524871 Modified gherlin peptides |
| 09/03/2013 | US8524862 Muteins of C5a anaphylatoxin and methods of inhibiting C5a |
| 09/03/2013 | US8524776 Use of polyunsaturated ketones for the treatment of psoriasis |
| 09/03/2013 | US8524729 Cinnamoyl derivatives and use thereof |
| 09/03/2013 | US8524721 Platelet ADP receptor inhibitors |
| 09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/03/2013 | CA2707767C Biologically active peptides |
| 09/03/2013 | CA2687172C Anti-norovirus agent and composition containing the same |
| 09/03/2013 | CA2567704C Selective serotonin receptor inverse agonists as therapeutics for disease |
| 09/03/2013 | CA2522562C 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
| 09/03/2013 | CA2459807C Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 09/03/2013 | CA2421865C Olfactory and pheromones g-protein coupled receptors |
| 09/03/2013 | CA2398277C The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for protecting cns cells from glutamate toxicity |
| 09/03/2013 | CA2377515C Cytoplasmic transfer to de-differentiate recipient cells |
| 09/03/2013 | CA2241564C Wsx receptor and ligands |
| 08/29/2013 | WO2013126017A1 Organogels and emulsions for biological and non-biological applications |
| 08/29/2013 | US20130225490 Antibodies That Inhibit TSLP Activity |
| 08/29/2013 | US20130224769 Methods of using chemokine panec-1 antibodies |
| 08/29/2013 | US20130224301 Solid pharmaceutical dispersions with enhanced bioavailability |
| 08/29/2013 | US20130224241 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
| 08/28/2013 | EP2631229A1 P2x4 receptor antagonist |
| 08/28/2013 | EP2630122A1 Arylamide derivatives as ttx-s blockers |
| 08/28/2013 | EP2629772A1 Method of treating hemorrhoids using macrocyclic lactone compound |
| 08/28/2013 | EP2629770A1 Method of treating otitis externa using macrocyclic lactone compound |
| 08/28/2013 | CN1538951B Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |
| 08/28/2013 | CN103263627A Medicine for treating oblique inguinal hernia and preparation method thereof |
| 08/28/2013 | CN103263407A Inductive production-increase agent for honeybee pollination on flowering plants |
| 08/28/2013 | CN102470133B Quinoline derivative-containing pharmaceutical composition |
| 08/28/2013 | CN102406830B Room-temperature preparation method for submicron powder Qingshu powder and special bidirectional airflow screening machine |
| 08/28/2013 | CN102245759B Technique for regulating regeneration of tissue or faulty or abnormal part in organ using NELL-1 |
| 08/28/2013 | CN102123986B Pharmaceutical compositions |
| 08/28/2013 | CN102093320B Soluble epoxide hydrolase inhibitor |
| 08/28/2013 | CN101970458B Novel gamma-secretase inhibitor |
| 08/28/2013 | CN101361718B Stable preparation method of decitabine freeze-dry preparation |
| 08/27/2013 | US8519109 Tumour rejection antigens |
| 08/27/2013 | US8519098 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 08/27/2013 | US8518999 Modulators of TNF-αsignaling |
| 08/27/2013 | US8518987 Pseudopolymorphic forms of a HIV protease inhibitor |
| 08/27/2013 | US8518973 Compounds having 4-pyridylalkylthio group as a substituent |
| 08/27/2013 | US8518936 Method for preparing acid addition salts of polyacidic basic compounds |
| 08/27/2013 | US8518897 Method of treatment for cancers associated with elevated HER2 levels |
| 08/27/2013 | US8518893 Medical compositions containing ghrelin |
| 08/27/2013 | US8518890 Luteinizing hormone-releasing hormone receptor agonist leuprorelin, or antagonist with androgen receptor agonist for prophylaxis, treatment of prostate cancer; dehydroepiandrosterone, testosterone, dihydrotestosterone; non-steroidal androgen receptor agonist; estradiol, estrone, estriol, stilbestrol |
| 08/27/2013 | US8518655 Means for the diagnosis and therapy of CTCL |
| 08/27/2013 | US8518460 Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis |
| 08/27/2013 | US8518443 Opioid agonist formulations with releasable and sequestered antagonist |
| 08/27/2013 | US8518421 Flashmelt oral dosage formulation |
| 08/27/2013 | CA2678754C Process for the preparation and purification of thiol-containing maytansinoids |
| 08/27/2013 | CA2678722C Antihypertensive combination of valsartan and a calcium channel blocker |
| 08/27/2013 | CA2531868C Process for the preparation of thalidomide |
| 08/27/2013 | CA2497989C Probiotic bacterium: lactobacillus fermentum |
| 08/27/2013 | CA2291861C Zinc finger protein derivatives and methods therefor |
| 08/22/2013 | WO2013123218A1 Selective estrogen receptor modulators with short half-lives and uses thereof |
| 08/22/2013 | WO2013120229A1 METHOD FOR PREPARING AQUEOUS MANO PARTICLE SUSPENSIONS OF DERIVATIVES OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURAN ALIPHATIC ACID ESTERS |
| 08/22/2013 | US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/22/2013 | US20130217676 5ht2c receptor modulators |
| 08/22/2013 | US20130216571 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
| 08/22/2013 | US20130216496 Methods for treating tweak-related conditions |
| 08/21/2013 | EP2628798A1 Prophylactic or therapeutic agent for fibrosis |
| 08/21/2013 | EP2628733A1 Acylbenzene derivative |
| 08/21/2013 | EP2628488A1 Sustained-release pharmaceutical composition |
| 08/21/2013 | EP2143437B1 Compositions and methods for the diagnosis and treatment of tumor |
| 08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
| 08/21/2013 | CN103261413A Marker for determination of sensitivity to triplet combination anti-cancer agent |
| 08/21/2013 | CN103261412A Antihuman CCR7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-mmobilized carrier |